Find Reports
Select Report Type
Reimbursement Review
Displaying 826 - 850 of 1422
Please scroll or swipe to the right to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| OnabotulinumtoxinA | Botox | OnabotulinumtoxinA | Neurogenic detrusor overactivity | List with clinical criteria and/or conditions | Complete | SR0268-000 | |||
| Tocilizumab | Actemra | Tocilizumab | Arthritis, juvenile idiopathic | List with clinical criteria and/or conditions | Complete | SR0267-000 | |||
| Asenapine | Saphris | Asenapine | Bipolar I disorder | List with clinical criteria and/or conditions | Complete | SR0262-001 | |||
| Asenapine | Saphris | Asenapine | Schizophrenia | Do not list | Complete | SR0262-000 | |||
| Prasugrel | Effient | Prasugrel | Acute coronary syndrome | Do not list | Complete | SR0263-000 | |||
| Apixaban | Eliquis | Apixaban | Venous thromboembolic events, prevention | List with clinical criteria and/or conditions | Complete | SR0264-000 | |||
| Zelboraf for Advanced Melanoma... | Zelboraf | Vemurafenib | Metastatic Melanoma | Reimburse with clinical criteria and/or conditions | Complete | PC0006-000 | |||
| Oxybutynin Chloride Gel | Gelnique | Oxybutynin Chloride Gel | Overactive bladder | Do not list | Complete | SR0260-000 | |||
| Mometasone furoate | ASMANEX | Mometasone furoate | Asthma | List | Complete | SR0258-000 | |||
| Sutent for pancreatic neuroend... | Sutent | Sunitinib malate | Pancreatic Neuroendocrine Tumour | Reimburse with clinical criteria and/or conditions | Complete | PC0004-000 | |||
| Dexamethasone intravitreal imp... | Ozurdex | Dexamethasone intravitreal implant | Macular edema, central retinal vein occlusion | Do not list | Complete | SR0247-000 | |||
| Belimumab | Benlysta | Belimumab | Systemic lupus erythematosus | Do not list | Complete | SR0251-000 | |||
| Silodosin | RAPAFLO | Silodosin | Benign prostatic hyperplasia | Do not list | Complete | SR0261-000 | |||
| Rivaroxaban | Xarelto | Rivaroxaban | Atrial fibrillation, stroke prevention | List with clinical criteria and/or conditions | Complete | SR0257-000 | |||
| Dienogest | Visanne | Dienogest | Pain, pelvic pain associated with endometriosis | List with clinical criteria and/or conditions | Complete | SR0255-000 | |||
| Emtricitabine/ rilpivirine/ te... | COMPLERA | Emtricitabine/ rilpivirine/ tenofovir disoproxil fumarate | HIV infection | List | Complete | SR0256-000 | |||
| Yervoy for advanced melanoma -... | Yervoy | Ipilimumab | Advanced Melanoma | Reimburse with clinical criteria and/or conditions | Complete | PC0003-000 | |||
| Ranibizumab | Lucentis | Ranibizumab | Macular edema, diabetic | List with clinical criteria and/or conditions | Complete | SR0253-000 | |||
| Rufinamide | Banzel | Rufinamide | Lennox-Gastaut syndrome | List with clinical criteria and/or conditions | Complete | SR0252-000 | |||
| Rilpivirine | Edurant | Rilpivirine | HIV infection | List | Complete | SR0243-000 | |||
| Linagliptin | Trajenta | Linagliptin | Diabetes mellitus, type 2 | List with clinical criteria and/or conditions | Complete | SR0244-000 | |||
| Telaprevir | Incivek | Telaprevir | Hepatitis C, chronic | List with clinical criteria and/or conditions | Complete | SR0249-000 | |||
| Fentanyl Citrate | Onsolis | Fentanyl Citrate | Pain, breakthrough cancer pain | Do not list | Complete | SR0248-000 | |||
| Oxycodone HCI / naloxone HCI | Targin | Oxycodone HCI / naloxone HCI | Pain, moderate to severe and relief of opioid-induced constipation | Do not list | Complete | SR0241-000 | |||
| Votrient for metastatic renal ... | Votrient | Pazopanib hydrochloride | Metastatic Renal Cell Carcinoma | Reimburse | Complete | PC0000-000 |
Health Technology Review
Displaying 576 - 600 of 600
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 826 - 850 of 2132
Please scroll or swipe to the right to view the full content.
| Title | Description | Files | Last Updated Sort ascending | Project Line | Project Sub Line | Status | Project Number |
|---|---|---|---|---|---|---|---|
| Infliximab for Graft versus Host Disease | Health Technology Review | Summary of Abstracts | Completed | RB1621-000 | |||
| Assessment of Postoperative Vital Signs Frequency | Health Technology Review | Summary of Abstracts | Completed | RB1620-000 | |||
| Removable Rigid Dressings for the Post-Operative Management of Leg Amputations | Health Technology Review | Summary with Critical Appraisal | Completed | RC1432-000 | |||
| Private IV Infusion Clinics in Canada | Health Technology Review | Environmental Scan | Completed | ES0365-000 | |||
| Intranasal Glucagon for the Treatment of Hypoglycemia | Health Technology Review | Summary with Critical Appraisal | Completed | RC1435-000 | |||
| Ibrutinib for Chronic Graft versus Host Disease | Health Technology Review | Summary with Critical Appraisal | Completed | RC1433-000 | |||
| Formulary Management of Targeted Immune Modulators for Ulcerative Colitis | Health Technology Review | Technology Review | In Progress | HD0010-000 | |||
| CADTH Pharmaceutical Reviews Update — Issue 30 | Reimbursement Review | Pharmaceutical Review Update | |||||
| Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastric, Gastroesophageal Junction (GEJ), or Esophageal Cancer | Reimbursement Review | Provisional Funding Algorithm | Complete | PH0010-000 | |||
| Stereotactic Ablative Radiotherapy for the Treatment of Oligometastatic Cancer | Health Technology Review | Completed | HT0029-000/HT0029-004 | ||||
| tralokinumab | Reimbursement Review | Complete | SR0689-000 | ||||
| inclisiran | Reimbursement Review | Complete | SR0681-000 | ||||
| prasterone | Reimbursement Review | Complete | SR0707-000 | ||||
| Alpha1-proteinase inhibitor (Human) | Reimbursement Review | Complete | ST0702-000 | ||||
| Utilization of Cholinesterase Inhibitors for Alzheimer’s Disease in Canada | Health Technology Review | Technology Review | Completed | HC0027-000 | |||
| Self-Collection of Nose and Throat Swab Samples for SARS-CoV-2 Antigen Testing | Horizon Scan | Emerging Health Technologies | Completed | EH0109-000 | |||
| Utilization of Old versus New Generation Biologics for Public and Private Insurers in Canada | Health Technology Review | Technology Review | Completed | HC0020-000 | |||
| Dapagliflozin for Chronic Kidney Disease | Health Technology Review | Rapid Review with Expert Input | RD0065-000 | ||||
| Melatonin for the Treatment of Insomnia in Children and Adolescents | Health Technology Review | Rapid Review | Completed | RC1423-000 | |||
| pemigatinib | Reimbursement Review | Complete | PC0252-000 | ||||
| aducanumab | Reimbursement Review | Withdrawn | SR0705-000 | ||||
| Systemic Thrombolysis by Alteplase for Acute Ischemic Stroke | Health Technology Review | Rapid Review with Expert Input | Completed | RD0066-000 | |||
| Monitoring Patients With Psychotic Disorders for Clozapine-Induced Myocarditis or Cardiomyopathy | Health Technology Review | Rapid Review | RC1429-000 | ||||
| Guidelines for Pediatric Immune Thrombocytopenia | Health Technology Review | Rapid Review | RC1426-000 | ||||
| CADTH Pharmaceutical Reviews Update — Issue 29 | Reimbursement Review | Pharmaceutical Review Update |